Avadel Told To Pay Jazz Pharma $234K Over Narcolepsy Drug IP
By Andrew Karpan · March 5, 2024, 6:29 PM EST
A Delaware federal jury found Monday that a specialty drugmaker owes nearly $234,000 to drug manufacturer Jazz Pharmaceuticals Inc. for using a patented process behind its newer narcolepsy drug, launched last...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login